Li Wei
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Glycosylation and Glycoproteins Research 1
-
- Macrophage Migration Inhibitory Factor 2
- Co-authors
- Dongsheng Zhao (1 shared paper)Qing Liang (1 shared paper)Ping Zhu (1 shared paper)Jin Qi (2 shared papers)Kejia Wang (1 shared paper)YS Chan (1 shared paper)Jinshen Wang (2 shared papers)Pengcheng Liu (2 shared papers)
- Journals
- PLoS ONE (2 papers)Pharmacoepidemiology and Drug Safety (1 paper)CNS & Neurological Disorders - Drug Targets (1 paper)IEEE Transactions on Industrial Informatics (1 paper)Applied Materials Today (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Li Wei
23 papers receiving 241 citations
Peers
Comparison fields: 5 of 82
- Family Practice 5
- Cancer Research 37
- Developmental Neuroscience 8
- Genetics 19
- Molecular Biology 95
Countries citing papers authored by Li Wei
This map shows the geographic impact of Li Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Wei more than expected).
Fields of papers citing papers by Li Wei
This network shows the impact of papers produced by Li Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Wei. The network helps show where Li Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 33 | |
| 2 | 2014 | 28 | |
| 3 | 2011 | 28 | |
| 4 | 2015 | 24 | |
| 5 | 2021 | 23 | |
| 6 | 2015 | 18 | |
| 7 | 2022 | 17 | |
| 8 | 2011 | 11 | |
| 9 | 1997 | 11 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 10 | |
| 12 | 2014 | 8 | |
| 13 | 2020 | 7 | |
| 14 | 2012 | 6 | |
| 15 | 2024 | 3 | |
| 16 | 2020 | 3 | |
| 17 | 2026 | 2 | |
| 18 | 2022 | 1 | |
| 19 | Searching for the Peptide Ligands of Interleukin-2 in Phage-displayed Peptide Library | 1999 | 1 |
| 20 | Research on Development of Sport Academic Journal of New China | 2009 | 1 |
About Li Wei
Li Wei is a scholar working on Molecular Biology, Immunology, Public Health, Environmental and Occupational Health, Surgery and Cellular and Molecular Neuroscience, having authored 25 papers that have together received 249 indexed citations. Recurring topics across this work include Nuclear Receptors and Signaling (2 papers), Macrophage Migration Inhibitory Factor (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Ophthalmology and Visual Impairment Studies (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Glycosylation and Glycoproteins Research (1 paper), Diverse Approaches in Healthcare and Education Studies (1 paper) and Telemedicine and Telehealth Implementation (1 paper). The work is most often cited by research in Family Practice (5 citations), Cancer Research (37 citations), Developmental Neuroscience (8 citations), Genetics (19 citations) and Molecular Biology (95 citations). Li Wei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dongsheng Zhao, Qing Liang, Ping Zhu, Jin Qi, Kejia Wang, YS Chan, Jinshen Wang, Pengcheng Liu, Wei Zhang and Fei Kuang. Their work appears in journals such as PLoS ONE, Pharmacoepidemiology and Drug Safety, CNS & Neurological Disorders - Drug Targets, IEEE Transactions on Industrial Informatics and Applied Materials Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.